Biometals 27 , 13711382 (2014)
Trulicity is also approved to lower the risk of major cardiovascular events such as heart attack or stroke in adults with type 2 diabetes and heart disease
Arruda-Junior DF, Martins FL, Salles TA, Jensen L, Dariolli R, Antonio EL, Dos Santos L, Crajoinas RO, Tucci PJF, Gowdak LHW, et al
Reissued Date: The date of reissue of a corrected patent, where errors in the patents were made without any deceptive intention
A 2025 study in the American Journal of Ophthalmology did not find a significant increase in NAION or ischemic optic neuropathy risk in patients taking semaglutide or GLP-1 medications compared with diabetes or high-BMI control groups
In 2023, the Federal Employee Health Benefits Program, which sponsors health insurance for millions of government workers, directed its insurers to provide coverage for at least one drug like Wegovy